We observed synergistic growth inhibition at a wide range of concentrations of 7c and olaparib in both cell lines (Figure 5b), indicating that 7c could sensitize FLT3-ITD+ AML cells to PARP inhibition. This evidence concerns the gene PARP1 and acute myeloid leukemia.